Lataa...

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition

OBJECTIVE: Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ketoacidosis (euDKA) in hopes that it will enhance recognition of this potentially life-threatening complicatio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Care
Päätekijät: Peters, Anne L., Buschur, Elizabeth O., Buse, John B., Cohan, Pejman, Diner, Jamie C., Hirsch, Irl B.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Diabetes Association 2015
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4542270/
https://ncbi.nlm.nih.gov/pubmed/26078479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc15-0843
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!